<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib144">
 <element-citation publication-type="journal" id="sref144">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>R.-R.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Q.-H.</given-names>
   </name>
   <name>
    <surname>Luo</surname>
    <given-names>R.-H.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>Y.-M.</given-names>
   </name>
   <name>
    <surname>Dai</surname>
    <given-names>S.-X.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.-J.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Cui</surname>
    <given-names>X.-Q.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.-J.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>J.-F.</given-names>
   </name>
  </person-group>
  <article-title>Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro</article-title>
  <source>PloS One</source>
  <volume>9</volume>
  <year>2014</year>
 </element-citation>
</ref>
